EUVIMEDEUVIMED entdecken
Crossref

Discovery of Novel PTP1B Inhibitors with Once-Weekly Therapeutic Potential for Type 2 Diabetes: Design, Synthesis, and In Vitro and In Vivo Investigations of BimBH3 Peptide Analogues

Chuanliang Zhang iD, Xianmin Yang, Xinjia Meng, Lijuan Wu, Xiaochun Liu, Jiangming Gao, Shan Liu, Juan Wu, Dingmin Huang, Zhenwei Wang, Xianbin Su

Journal of Medicinal Chemistry · 2023

DOI: 10.1021/acs.jmedchem.2c02003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2023. Verfasst von Chuanliang Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemical Engineering, Qingdao University of Science and Technology, Qingdao 266042, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Enzyme Inhibitors, Hypoglycemic Agents, Protein Tyrosine Phosphatase, Non-Receptor Type 1. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: Qingdao University of Science and Technology, National Natural Science Foundation of China, Natural Science Foundation of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Enzyme InhibitorsHypoglycemic AgentsProtein Tyrosine Phosphatase, Non-Receptor Type 1Drug DesignHumansInsulinMolecular Docking Simulation

Substanzen

Enzyme InhibitorsHypoglycemic AgentsInsulinPTPN1 protein, humanProtein Tyrosine Phosphatase, Non-Receptor Type 1

Autor:innen und Institutionen

  • College of Chemical Engineering, Qingdao University of Science and Technology, Qingdao 266042, China.
  • School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China.
  • Marine Biomedical Research Institute, Ocean University of China, Qingdao 266071, China.

ORCID-Profile: Chuanliang Zhang

Förderung

  • Qingdao University of Science and Technology
  • National Natural Science Foundation of China
  • Natural Science Foundation of Shandong Province
  • Province and Ministry Co-construction Collaborative Innovation Center of Eco-Chemical Engineering, Qingdao University of Science and Technology

Zitieren

APA

Zhang, C., Yang, X., Meng, X., Wu, L., Liu, X., Gao, J., Liu, S., Wu, J., Huang, D., Wang, Z., & Su, X. (2023). Discovery of Novel PTP1B Inhibitors with Once-Weekly Therapeutic Potential for Type 2 Diabetes: Design, Synthesis, and In Vitro and In Vivo Investigations of BimBH3 Peptide Analogues. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.2c02003

Vancouver

Zhang C, Yang X, Meng X, Wu L, Liu X, Gao J, et al. Discovery of Novel PTP1B Inhibitors with Once-Weekly Therapeutic Potential for Type 2 Diabetes: Design, Synthesis, and In Vitro and In Vivo Investigations of BimBH3 Peptide Analogues. Journal of Medicinal Chemistry. 2023. doi:10.1021/acs.jmedchem.2c02003

BibTeX
@article{Zhang2023,
  author = {Zhang, Chuanliang and Yang, Xianmin and Meng, Xinjia and Wu, Lijuan and Liu, Xiaochun and Gao, Jiangming and Liu, Shan and Wu, Juan and Huang, Dingmin and Wang, Zhenwei and Su, Xianbin},
  title = {Discovery of Novel PTP1B Inhibitors with Once-Weekly Therapeutic Potential for Type 2 Diabetes: Design, Synthesis, and In Vitro and In Vivo Investigations of BimBH3 Peptide Analogues},
  journal = {Journal of Medicinal Chemistry},
  year = {2023},
  doi = {10.1021/acs.jmedchem.2c02003}
}
Kostenlos starten →